# Treatment of Post-Stroke Central Pain

> **NCT07593313** · NA · RECRUITING · sponsor: **Nanchong Central Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Central Post-Stroke Pain

## Interventions

- **PROCEDURE:** stSCS+Gabapentin or Pregabalin (with optional Duloxetine or Amitriptyline)
- **DRUG:** Gabapentin or Pregabalin (with optional Duloxetine or Amitriptyline)

## Key facts

- **NCT ID:** NCT07593313
- **Lead sponsor:** Nanchong Central Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07593313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07593313, "Treatment of Post-Stroke Central Pain". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT07593313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*